Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Stryker

Stryker Stock Gets Relative Strength Rating Lift

A Relative Strength Rating upgrade for Stryker shows improving technical performance. Will it continue?

Investors Business Daily

Stryker Sees IBD RS Rating Climb To 71

A Relative Strength Rating upgrade for Stryker shows improving technical performance. Will it continue?

Investors Business Daily

If You Could Only Hold 3 Investments for Life, Consider These

Discover 3 must-own investments for lifelong growth. From dividend stocks to a market-beating ETF, these picks offer stability, returns, and long-term wealth.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Stryker Stock Outperforming the S&P 500?

Stryker has outperformed the S&P 500 recently, and analysts remain highly optimistic about the stock’s prospects.

Barchart

Stocks Showing Improving Market Leadership: Stryker Earns 81 RS Rating

Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 81.

Investors Business Daily

Stryker Shows Improved Relative Price Performance; Still Shy Of Benchmark

Stryker shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

Do Wall Street Analysts Like Stryker Stock?

Although Stryker has lagged behind the S&P 500 Index over the past year, Wall Street analysts remain strongly optimistic about the stock's prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Stryker Undercuts Breakout On Sales Deal, Despite Quarterly Beat

Stryker stock dipped late Tuesday after the medtech company beat forecasts, but announced its plan to divest the U.S. spinal business.

Investors Business Daily

Stocks Steady Before the Open After Tech-Fueled Selloff, FOMC Meeting on Tap

March S&P 500 E-Mini futures (ESH25) are up +0.09%, and March Nasdaq 100 E-Mini futures (NQH25) are up +0.16% this morning, stabilizing after yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings…

Barchart

S&P Futures Gain Ahead of FOMC Meeting, U.S. Economic Data and Earnings on Tap

March S&P 500 E-Mini futures (ESH25) are trending up +0.42% this morning, partially rebounding from yesterday’s dramatic selloff, while investors awaited the start of the Federal Reserve’s two-day policy meeting as well as a flurry of U.S. economic data and corporate earnings reports.

Barchart

Stryker Had A Good Year Last Year; Here's How It's Looking For 2025

Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating.

Investors Business Daily

Earnings Preview: What to Expect from Stryker’s Report

With Stryker gearing up to release its fourth-quarter earnings later this month, analysts expect a significant double-digit growth in earnings.

Barchart

Inari Medical Catapults — Again — After Stryker Confirms $4.9 Billion Deal

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion. Inari stock catapulted Tuesday on the news.

Investors Business Daily

3 Stocks Helping to Bring AI to Healthcare

Many profitable companies are using AI to make healthcare more efficient; and these companies are rewarding investors with share price growth and dividends

MarketBeat

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

IBD Rating Upgrades: Stryker Shows Improved Technical Strength

Stryker shows improving price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

3 MedTech Stocks to Grab Now for a Strong 2025

This article highlights three MedTech stocks poised for growth in 2025

Barchart

How Is Stryker's Stock Performance Compared to Other Medical Device Stocks?

Stryker has substantially outpaced other medical device stocks over the past year and analysts remain strongly bullish on the stock’s prospects.

Benzinga

Cracking The Code: Understanding Analyst Reviews For Stryker

Ratings for Stryker (NYSE:SYK) were provided by 19 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Stryker Stock Outlook: Is Wall Street Bullish or Bearish?

Medtech giant Stryker has outperformed the broader market over the past year, and analysts remain moderately bullish on the stock’s prospects.

Investors Business Daily

Stryker Earns Relative Strength Rating Upgrade; Hits Key Threshold

A Relative Strength Rating upgrade for Stryker shows improving technical performance.

StockNews.com

3 Medical Devices Stocks Poised for Solid Growth

The medical device sector is evolving, driven by rising demand for precision technology in diagnostics. Therefore, it could be ideal to buy fundamentally solid medical device stocks Stryker Corp (SYK), Axogen (AXGN), and Zimmer Biomet Holdings (ZBH), which look poised for substantial growth. Read more….

Investors Business Daily

Stocks Generating Improved Relative Strength: Stryker

Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Barchart

Stryker's Quarterly Earnings Preview: What You Need to Know

Stryker is set to release its Q3 earnings next week, and analysts forecast a lower-double-digit rise in profits.

Fortune

HR leaders share how they're putting people first in an ever-changing workplace

HR professionals are navigating RTO, AI, cultural changes, and divisive virtual cultural issues.

Barchart

Stryker - Growth Through Aggressive M&A

Summary Stryker Corporation (SYK) shows strong technical buy signals, with a 6.09% gain since 8/21, and consistent price appreciation across key moving averages. The company operates in MedSurg, Neurotechnology, Orthopaedics, and Spine segments, offering a wide range of medical devices and technologies. Analysts provide mixed ratings, with price targets ranging...

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.